Clinical laboratories analyze patient specimens to provide information that helps healthcare professionals assess medical conditions and determine appropriate treatment strategies. The growing emphasis on preventive healthcare, regular health check-ups, and timely disease detection is increasing the importance of laboratory testing in the U.S. healthcare system. In addition, advancements in laboratory automation and diagnostic technologies are encouraging service providers to improve operational efficiency and testing capabilities.

According to Fortune Business Insights, the U.S. clinical laboratory services market size was worth USD 101.73 billion in 2023 and is projected to grow at a CAGR of 7.3% during the forecast period from 2024 to 2032. The market is supported by increasing healthcare expenditure, rising demand for routine diagnostic tests, and the growing prevalence of chronic and infectious diseases across the country. Clinical laboratory services play an essential role in identifying health conditions, supporting treatment decisions, monitoring disease progression, and promoting early diagnosis.

Top Companies In The Market

The U.S. clinical laboratory services market features established laboratory networks and specialized diagnostic service providers. Companies compete by expanding their testing portfolios, strengthening laboratory capabilities, improving service accessibility, and introducing advanced diagnostic solutions. Key companies identified by Fortune Business Insights include:

• Laboratory Corporation of America (U.S.)
• Quest Diagnostics Incorporated (U.S.)
• Illumina, Inc. (U.S.)
• Eurofins Scientific (Luxembourg)
• UNILABS (A.P. Moller Holding A/S) (Switzerland)
• NeoGenomics Laboratories, Inc. (U.S.)
• ARUP Laboratories (U.S.)
• Sonic Healthcare Limited (Australia)

Laboratory Corporation of America, Quest Diagnostics Incorporated, and Eurofins Scientific held prominent positions in the market in 2022, supported by their service portfolios and established presence. Strategic partnerships, acquisitions, and laboratory expansion initiatives remain important approaches for strengthening competitive positions and broadening access to diagnostic services.

Market Drivers & Restraints:

Market Drivers

• Growing prevalence of chronic diseases: Increasing cases of chronic and infectious conditions are generating demand for diagnostic testing. Laboratory services support the identification and monitoring of conditions such as diabetes, cardiovascular diseases, cancer, and other long-term disorders.
• Increasing focus on early diagnosis: Greater awareness of preventive healthcare and routine health examinations encourages patients and healthcare professionals to use laboratory testing for identifying potential health problems earlier.
• Healthcare expenditure and reimbursement support: Healthcare spending and public and private reimbursement arrangements support the adoption of clinical laboratory services across different patient groups.
• Advancements in laboratory automation: Automated equipment, laboratory workflow systems, and digital integration can improve operational processes and support the delivery of diagnostic services.

Market Restraints